Xiuzheng Pharmaceutical

Xiuzheng Pharmaceutical is a Chinese pharmaceutical corporate brand commonly associated with Xiuzheng Pharmaceutical Group and the Chinese name 修正药业. Its public-facing identity is centered on medicines and healthcare products sold primarily in China, with particular recognition in over-the-counter and traditional Chinese medicine categories. The group’s activities are generally described as spanning pharmaceutical research, manufacturing, distribution, and commercial promotion rather than being limited to a single medicine or therapeutic specialty. The brand operates in a healthcare environment where consumer recognition, pharmacy distribution, hospital access, manufacturing compliance, and product registration all influence commercial performance. Its portfolio is associated with both prescription and non-prescription medicines, although the strongest general-market association is with OTC products and Chinese medicines. As with other large domestic pharmaceutical groups, its business scope may also include pharmaceutical ingredients, health-related products, and medical or healthcare services, but the precise composition of the group and its subsidiaries should be verified against current corporate disclosures. Xiuzheng is principally a China-focused brand. The available information supplied for this entry does not establish a verified international operating footprint, public listing, revenue figure, or current executive roster. It is therefore best characterized as an active Chinese pharmaceutical corporate brand with substantial domestic-market relevance, while leaving ownership structure, founding details, headquarters, and financial status unconfirmed. The brand name should not be confused with unrelated businesses using similar transliterations or Chinese characters. Because no single authoritative Wikipedia path or equivalent disambiguating identifier was supplied, this dossier treats Xiuzheng as the pharmaceutical company associated with 修正药业, based on the supplied name, industry, country, and official website.

Xiuzheng Pharmaceutical is associated with the Chinese pharmaceutical enterprise commonly known as 修正药业 or Xiuzheng Pharmaceutical Group. The organization’s public identity is that of a domestic pharmaceutical manufacturer and healthcare company rather than a single-product consumer label. Its market profile is linked especially to OTC medicines and traditional Chinese medicines, while its broader activities are understood to include pharmaceutical research, production, distribution, and related healthcare businesses. The available reference material does not provide sufficiently verified details for a complete chronological history. In particular, the founding year, founder, original location, corporate-restructuring history, subsidiary structure, and changes in ownership or legal form cannot be confirmed from the information supplied for this entry. Those fields are therefore left unreported rather than inferred from secondary descriptions. Xiuzheng’s importance is best understood in the context of China’s large domestic medicines market. Pharmaceutical brands operating in this market typically combine regulated manufacturing with extensive pharmacy, hospital, distributor, and consumer channels. OTC medicines require strong retail availability and brand recognition, while traditional Chinese medicines depend on product registration, formulation standards, manufacturing controls, and consumer trust. Xiuzheng’s brand positioning reflects this combination of industrial pharmaceutical production and consumer-facing healthcare marketing. No verified public-listing information, ticker, financial history, or current executive list was supplied. The company should consequently not be described as a publicly traded issuer on the basis of its size or market presence. Likewise, no specific product, campaign, scandal, regulatory action, acquisition, or leadership change is included here because the available material does not identify one with adequate supporting documentation. Further research using the company’s current corporate disclosures, Chinese regulatory records, and reliable business reporting would be needed to expand the chronology.

A large domestic Chinese pharmaceutical brand positioned around accessible medicines and healthcare products, with particular visibility in OTC and traditional Chinese medicine categories.

• Over-the-counter medicinesOTC medicines

  Consumer medicines sold through retail pharmacies and other permitted channels. OTC products are the category most closely associated with Xiuzheng’s general-market brand recognition in the supplied reference material. No verified list of individual products or active ingredients was provided, so this entry records the category rather than naming specific formulations.

• Traditional Chinese medicinesTraditional Chinese medicine

  Medicines based on traditional Chinese medicine formulations and manufacturing practices. This category forms part of Xiuzheng’s reported pharmaceutical scope, but the available material does not establish a definitive list of branded products, dosage forms, or therapeutic indications.

• Prescription medicinesPrescription pharmaceuticals

  Regulated medicines intended for prescription or institutional healthcare channels. Xiuzheng is associated with a broader pharmaceutical portfolio beyond consumer OTC products, but no verified product catalogue or therapeutic-area breakdown was supplied for this dossier.

• Healthcare productsHealthcare and wellness

  Health-related products connected with the company’s wider healthcare positioning. The exact scope may vary by subsidiary and regulatory classification; the available reference material does not support naming specific supplements, devices, or wellness products.

1. Xiuzheng official website